Value Health. 2009 Jun;12(4):409-18. Epub 2009 Jan 12.

Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report.

Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J.

Source

Centre for Health Economics, University of York, York, UK. md18@york.ac.uk

Abstract

ABSTRACT A growing number of jurisdictions now request economic data in support of their decision-making procedures for the pricing and/or reimbursement of health technologies. Because more jurisdictions request economic data, the burden on study sponsors and researchers increases. There are many reasons why the cost-effectiveness of health technologies might vary from place to place. Therefore, this report of an ISPOR Good Practices Task Force reviews what national guidelines for economic evaluation say about transferability, discusses which elements of data could potentially vary from place to place, and recommends good research practices for dealing with aspects of transferability, including strategies based on the analysis of individual patient data and based on decision-analytic modeling.

Comment in

PMID:: 19900249; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report. [Value Health. 2009]
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D. Value Health. 2009 Nov-Dec; 12(8):1086-99. Epub 2009 Sep 10.
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. [Value Health. 2007]
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P. Value Health. 2007 Sep-Oct; 10(5):336-47.
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. [Value Health. 2003]
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.
Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR, ISPOR Task Force on Good Research Practices--Modeling Studies. Value Health. 2003 Jan-Feb; 6(1):9-17.
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I. [Value Health. 2010]
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.
Hay JW, Smeeding J, Carroll NV, Drummond M, Garrison LP, Mansley EC, Mullins CD, Mycka JM, Seal B, Shi L. Value Health. 2010 Jan-Feb; 13(1):3-7. Epub 2009 Oct 28.
Review Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. [Value Health. 2005]
Review Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, et al. Value Health. 2005 Sep-Oct; 8(5):521-33.

See reviews... See all...

Cited by 6 PubMed Central articles

Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review. [Cost Eff Resour Alloc. 2011]
Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review.
Hagenmeyer EG, Koltermann KC, Dippel FW, Schädlich PK. Cost Eff Resour Alloc. 2011 Oct 6; 9(1):15. Epub 2011 Oct 6.
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. [Clinicoecon Outcomes Res. 2011]
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application.
Goeree R, He J, O'Reilly D, Tarride JE, Xie F, Lim M, Burke N. Clinicoecon Outcomes Res. 2011; 3:89-104. Epub 2011 Jun 2.
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands. [Neuropsychiatr Dis Treat. 2011]
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands.
Hoogveldt B, Rive B, Severens J, Maman K, Guilhaume C. Neuropsychiatr Dis Treat. 2011; 7:313-7. Epub 2011 Jun 15.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Transferability of economic evaluations across jurisdictions: ISPOR Good Researc...
Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report.
Value Health. 2009 Jun ;12(4):409-18. Epub 2009 Jan 12 .

PubMed
Infection-induced antibodies against the major outer membrane protein of Campylo...
Infection-induced antibodies against the major outer membrane protein of Campylobacter jejuni mainly recognize conformational epitopes.
FEMS Microbiol Lett. 2007 Jul ;272(2):137-43. Epub 2007 May 22 .

PubMed
Genomic diversity of Campylobacter coli and Campylobacter jejuni isolates recove...
Genomic diversity of Campylobacter coli and Campylobacter jejuni isolates recovered from free-range broiler farms and comparison with isolates of various origins.
Appl Environ Microbiol. 2005 Oct ;71(10):6216-27.

PubMed
Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flage...
Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice.
Infect Immun. 2008 Jul ;76(7):3170-5. Epub 2008 Apr 21 .

PubMed
Occurrence and genotypes of Campylobacter in broiler flocks, other farm animals,...
Occurrence and genotypes of Campylobacter in broiler flocks, other farm animals, and the environment during several rearing periods on selected poultry farms.
Int J Food Microbiol. 2008 Jul 15 ;125(2):182-7. Epub 2008 Apr 4 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: